Dr. McCollum on Drug Sequences for Patients With CRC
A. David McCollum, MD
A. David McCollum, MD, Baylor-Sammons Cancer Center, discusses drug sequences for patients with colorectal cancer (CRC).
Patients with CRC are generally treated with a biologic drug in combination with chemotherapy. Over time, the intensity of the chemotherapy is modified or lightened to try to maintain benefit for as long as possible.
There is still debate about which maintenance therapy is best for frontline treatment, as well as what constitutes as enough progression for a patient to need second-line therapy, says McCollum.